We use cookies

Moalem Weitemeyer uses cookies, including cookies from third parties, needed to make the website work and to enhance the user experience. Cookies are also used to detect inexpediencies and to examine your interactions with our website. Read more about how we use cookies and take care of your data here

Necessary/functional

Statistical

Accept

14 October 2021

Moalem Weitemeyer assisted Eir Ventures 

Moalem Weitemeyer assisted Danish life science venture capital fund Eir Ventures with the investment in iSD Immunotech.

iSD Immunotech is a biotech company that develops novel peptide therapeutics for the treatment of severe systemic lupus erythematosus (SLE), and the company has just been granted its first US patent by the US Patent and Trademark Office.

Click here for the press release. 

Mattias Vilhelm Warnøe Nielsen

Partner

+45 30 37 96 95

Go to profile

Niels Christian Høgh Andersen

Senior Associate

+45 30 37 96 11

Go to profile

Nikolaj Lassen

Legal Consultant

+45 30 37 96 93

Go to profile